E
Lyell Immunopharma, Inc. LYEL
$10.61 -$0.3626-3.31% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -57.61% -46.50% -46.18% -7.31% -0.36%
Total Depreciation and Amortization -18.94% -10.86% -3.06% -2.83% 1.70%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 381.34% 241.94% 247.15% -37.86% -54.19%
Change in Net Operating Assets -21,665.12% -309.94% -191.20% 96.57% 99.90%
Cash from Operations -8.24% -9.79% 0.79% 4.62% 2.65%
Capital Expenditure 11.02% 42.52% 82.73% 93.86% 94.09%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 154.49% 15.34% -17.40% -109.25% -63.92%
Cash from Investing 108.44% -2.30% -33.48% -109.59% -62.22%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -67.64% -43.60% -36.27% -18.81% -73.82%
Repurchase of Common Stock 100.00% 100.00% 83.37% 53.50% 28.62%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -58.74% -29.31% -23.92% -10.77% -77.70%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 63.36% -124.15% -274.88% -209.42% -588.00%